Beclometasone
Beclometasone structure
|
Common Name | Beclometasone | ||
|---|---|---|---|---|
| CAS Number | 4419-39-0 | Molecular Weight | 521.042 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 630.5±55.0 °C at 760 mmHg | |
| Molecular Formula | C22H29ClO5 | Melting Point | 210ºC | |
| MSDS | Chinese USA | Flash Point | 335.1±31.5 °C | |
|
In vitro performance of spacers for aerosol delivery during adult mechanical ventilation.
J. Aerosol Med. Pulm. Drug Deliv. 28(2) , 130-6, (2015) During mechanical ventilation, different aerosol generators are employed with various interfaces. The objective of this study was to evaluate the performance of a range of spacers, including a new device called Combihaler® designed for connection with both ne... |
|
|
In vitro evaluation of nonconventional accessory devices for pressurized metered-dose inhalers.
Ann. Allergy Asthma Immunol. 113(1) , 55-62, (2014) The selection of accessory devices for pressurized metered-dose inhalers (pMDIs) by health care professionals is typically cost driven without consideration of how the device modifies clinical outcomes.To evaluate nonconventional accessory devices and the ope... |
|
|
Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology.
Int. J. Pharm. 444(1-2) , 193-9, (2013) The aerosol properties of niosomes were studied using Aeroneb Pro and Omron MicroAir vibrating-mesh nebulizers and Pari LC Sprint air-jet nebulizer. Proniosomes were prepared by coating sucrose particles with Span 60 (sorbitan monostearate), cholesterol and b... |
|
|
The inverse agonist propranolol confers no corticosteroid-sparing activity in mild-to-moderate persistent asthma.
Clin. Sci. 127(11) , 635-43, (2014) The murine asthma model shows that switching off airway β2 receptors with an inverse agonist may confer anti-inflammatory effects as well as corticosteroid-sparing activity. We have assessed for any corticosteroid-sparing effects of propranolol, an inverse ag... |
|
|
Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
Respir. Med. 106 Suppl 1 , S9-19, (2012) Fixed-dose combinations of inhaled corticosteroids (ICSs) and long-acting β2-agonists (LABAs) have been used to manage asthma for several years. They are the preferred therapy option for patients who do not achieve optimal control of their asthma with low-dos... |
|
|
[Local antibacterial therapy for the inflammatory diseases of the external and middle ear].
Vestn. Otorinolaringol. (3) , 92-4, (2012) The objective of the present study was to estimate the efficacy and safety of candibioic designed for the treatment of the patients presenting with diffuse otitis externa and chronic otitis media. The open randomized trial included 40 patients with diffuse ot... |
|
|
Beclometasone Oral - DOR BioPharma: Beclomethasone Oral - DOR BioPharma.
Drugs R. D. 9(4) , 271-6, (2008)
|
|
|
Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Cochrane Database Syst. Rev. (4) , CD005309, (2005) The relative efficacy of fluticasone (FP) and beclomethasone (BDP) propelled with CFCs has been well established. The potency of HFA-BDP is thought to have been improved with new propellant and some studies suggest that it may equipotent at half the dose of C... |
|
|
[Characteristics of the latent period of sensorimotor reactions in middle-aged and elderly outpatients with asthma during long-term treatment with inhaled glucocorticosteroids].
Ter. Arkh. 84(8) , 41-4, (2012) To study a relationship of the characteristics of simple and complex visual sensorimotor reactions to asthma controllability in middle-aged and elderly outpatients during disease-modifying antirheumatic drug therapy with beclomethasone, fluticasone, or budeso... |
|
|
Improvements in delivery with an extra fine beclomethasone aerosol.
Int. J. Clin. Pract. Suppl. 96 , 28-32, (1998) The reformulation of beclomethasone dipropionate (BDP) in a chlorofluorocarbon (CFC)-free propellant, hydrofluoroalkane (HFA), has resulted in improved delivery of medication to the large and small airways, the target site of action of anti-asthmatic therapy.... |